Thu Sep 19 05:53:12 UTC 2024: ## OKYO Pharma Shares Plunge 24.3% Amidst Trading Volume Decline
**London, UK – September 19, 2024:** Shares of OKYO Pharma Limited (LON:OKYO), a preclinical biopharmaceutical company focused on developing treatments for eye diseases, experienced a sharp decline of 24.3% during midday trading on Wednesday. The stock hit a low of GBX 1.40 ($0.02) before settling at the same price. Trading volume for the day was significantly lower than the average, with only 364,142 shares changing hands, representing a 16% decrease.
The company’s lead product, OK-101, is being developed to treat dry eye disease. OKYO Pharma is also working on OK-201, a potential treatment for neuropathic ocular pain.
Despite the significant drop in share price, OKYO Pharma’s financial ratios remain relatively stable, with a current ratio of 0.83, a quick ratio of 2.65, and a debt-to-equity ratio of 1.65. The company’s market capitalization stands at £23.24 million.
The market’s reaction to OKYO Pharma’s share price decline may be related to a variety of factors, including recent developments in the company’s clinical trials or broader market trends. Further analysis is required to determine the specific cause of the significant drop.
First Piper 